How Will the Exosome Diagnostic And Therapeutic Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the exosome diagnostic and therapeutic market grown in recent years?
The market size for exosome diagnostic and therapeutic solutions has seen significant expansion over the recent years. Its growth is projected to escalate from $0.47 billion in 2024 to $0.61 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.1%. Factors contributing to this growth during the historic period include developments in biological research, the advent of precision medicine, breakthroughs in biomedical imaging, progress in cancer research and oncology, and investments in the healthcare sector.
How is the exosome diagnostic and therapeutic market size expected to evolve during the forecast period?
The market size of exosome diagnostic and therapeutic is predicted to witness a significant surge in the forthcoming years, with a projection to inflate to $1.63 billion by 2029, rising at a compound annual growth rate (CAGR) of 28.0%. This burgeoning growth in the given projection interval is owing to the enhanced clinical applications, conjunction with digital health technologies, accommodating regulatory settings, gene alteration and RNA treatments, and a broader involvement in immuno-oncology. Key trends within the forecast span include drug discovery based on exosome, biomimetic engineering of exosome, product commercialization of exosomes, therapeutic cargo loaded with exosomes, and liquid biopsy for cancer detection.
Get your exosome diagnostic and therapeutic market report here!
Which key drivers are propelling the exosome diagnostic and therapeutic market’s growth?
The escalating occurrence of chronic illnesses is anticipated to stimulate the expansion of the exosome diagnostic and therapeutic market in the future. Such illnesses last for three months or longer and may worsen over time. The diagnostic and therapeutic utilization of exosomes serve as potential biomarkers in cancer, providing more sensitive, personalized medical treatment options. For example, the National Center for Biotechnology Information (NCBI), a U.S. National Library of Medicine, predicts that by 2050, there will be 142.66 million individuals worldwide suffering from chronic diseases. This increasing prevalence of chronic diseases is consequently fueling the growth of the exosome diagnostics and therapeutics market.
What are the market segments in the exosome diagnostic and therapeutic industry?
The exosome diagnostic and therapeutic market covered in this report is segmented –
1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
Subsegments:
1) By Instruments: Exosome Isolation Systems, Characterization Instruments, Analysis Devices
2) By Software: Data Analysis Software, Exosome Profiling Software, Laboratory Management Software
3) By Reagents And KITS: Isolation KITS, Characterization Reagents, Assay KITS
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp
Which leading companies are shaping the growth of the exosome diagnostic and therapeutic market?
Major companies operating in the exosome diagnostic and therapeutic market include Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.
What key trends are currently impacting the exosome diagnostic and therapeutic market’s development?
Leading businesses in the exosome diagnostic and therapeutic market are creating new producats like sample purification systems to cater to a wider customer reach, boost sales, and upsurge revenue. A sample purification method involves the application and implementation of procedures and techniques intended to extract unwanted elements and pollutants from a sample which includes DNA, RNA, proteins, and other biomolecules. For instance, in 2023, Biological Dynamics Inc., a US firm specializing in biotechnology, introduced ExoVerita, an exosome-separation platform intended for early disease detection and other purposes. The ExoVita Pancreas assay detects specific exosomal protein markers and has demonstrated its ability to detect Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) using blood-derived exosome samples enriched on the ExoVerita machine that is protected by patents. The firm will leverage these findings to analyze samples from the ExoLuminate registry trial (NCT05625529) that has now started to actively enroll patients with high-risk PDAC to assess the test’s clinical significance. Eligibility for the trial is extended to patients who show clinical symptoms such as pancreatitis or identifiable pancreatic lesions, those with a genetic or familial inclination, and newly identified diabetics aged above 50.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12346
Which geographic areas are influencing the growth of the exosome diagnostic and therapeutic market?
North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Liquid Biopsy For Cancer Diagnostics Global Market Report 2024
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2024
Thyroid Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
